Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who have cirrhosis (serious scarring of the liver) that has been confirmed either by a liver biopsy or by a specific liver scoring test (called the Agile F score) showing advanced scarring.
- People whose liver disease is linked to a fatty liver condition (NAFLD), confirmed by at least one of the following: a biopsy showing fat in the liver, a liver scan result above certain thresholds, or — if scan results are below those thresholds — a diagnosis of type 2 diabetes and/or two or more features of metabolic syndrome lasting at least 5 years (confirm with trial site).
Who may not be able to join:
- People who do not wish to give their consent to participate.
- People whose alcohol consumption is above a certain weekly limit (more than 14 grams per week for women or 21 grams per week for men — confirm with trial site).
- People whose liver disease is caused by something other than a fatty liver condition.
- People with a liver disease severity score (called MELD) above 12, indicating more advanced liver disease.
- People with liver or other cancers where life expectancy is expected to be less than 2 years.
- People who have previously had liver surgery, a procedure called TIPS (a shunt placed in the liver), or a procedure to reduce blood flow to the spleen.
- People who have previously experienced serious complications from their liver disease (such as fluid build-up in the abdomen or bleeding from the digestive tract — confirm with trial site).
- People who are unable to fit into an MRI scanner (assessed using a simple physical check).
- People who cannot safely receive MRI contrast dye, including those with reduced kidney function (a kidney filtration rate below 30 ml/min).
- People with any other medical reason that prevents them from having an MRI scan.
- People who are pregnant.
- People currently experiencing sudden or acute kidney problems.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohammad S Siddiqui, MD, Virginia Commonwealth University
Phone: 804-828-4060
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of deaths; Incidents of variceal hemorrhage; Incidents of ascites; Hepatic Encephalopathy (HE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.